Condition
Pancreatic Ductal Adenocarcinoma (mPDAC) clinical trials and research
Research outlook What's coming for Pancreatic cancer: the next 6 months to 5 yearsAs of November 12, 2026, Find a Trial lists 3 Pancreatic Ductal Adenocarcinoma (mPDAC) clinical trials that are recruiting, at sites in 3 countries (most in United States (1), South Korea (1), France (1)). By phase: Phase 2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3Clinical trials
- 3Countries
Newest Pancreatic Ductal Adenocarcinoma (mPDAC) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| First-in-human dose study of DA-3501 for CLDN18.2-positive stomach, GEJ cancer, and pancreatic cancer | Phase 1 | Seongnam, Bundang and 2 other locations | Recruiting | Mar 18, 2026 |
| Immune suppression after Whipple (pancreaticoduodenectomy) | — | Lyon and 3 other locations | Recruiting | Aug 28, 2025 |
| Cemiplimab plus gemcitabine for metastatic pancreatic cancer with SWI/SNF gene changes | Phase 2 | La Jolla, California | Recruiting | Jan 24, 2025 |
All recruiting trials (3)
-
First-in-human dose study of DA-3501 for CLDN18.2-positive stomach, GEJ cancer, and pancreatic cancer
A first-in-human study tests DA-3501 in adults with CLDN18.2-positive advanced stomach/GEJ cancer or pancreatic cancer to find a safe, effective dose.
-
Immune suppression after Whipple (pancreaticoduodenectomy)
This will test whether measuring patients' immune function (mHLA-DR) after a Whipple operation for a pancreatic head tumor can identify people at higher risk of serious infections or pancreatic complications.
-
Cemiplimab plus gemcitabine for metastatic pancreatic cancer with SWI/SNF gene changes
This trial will test whether adding the immunotherapy cemiplimab to the chemotherapy gemcitabine helps people with metastatic pancreatic ductal adenocarcinoma who have SWI/SNF genetic alterations and have already received one prior chemotherapy regimen.
Related topics
Quick answers
How many Pancreatic Ductal Adenocarcinoma (mPDAC) clinical trials are recruiting right now?
3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (1 trial), South Korea (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.